UPLOAD Filing
GRI Bio, Inc.
Date: Aug. 22, 2025 · CIK: 0001824293 · Accession: 0000000000-25-009011
AI Filing Summary & Sentiment
Reasoning
Letter
August 22, 2025 Marc Hertz Chief Executive Officer GRI Bio, Inc. 2223 Avenida de la Playa, #208 La Jolla, CA 92037 Re:GRI Bio, Inc. Draft Registration Statement on Form S-1 Submitted August 15, 2025 CIK No. 0001824293 Dear Marc Hertz: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Hannah Karraker, Esq.
Show Raw Text
August 22, 2025
Marc Hertz
Chief Executive Officer
GRI Bio, Inc.
2223 Avenida de la Playa, #208
La Jolla, CA 92037
Re:GRI Bio, Inc.
Draft Registration Statement on Form S-1
Submitted August 15, 2025
CIK No. 0001824293
Dear Marc Hertz:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement and non-public draft
submission on EDGAR at least two business days prior to the requested effective date and
time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Hannah Karraker, Esq.